rubitecan has been researched along with Leukemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeJesus, A; Early, J; Giovanella, B; Kozielski, A; Mendoza, J; Pantazis, P; Vardeman, D | 1 |
| DeJesus, A; Giovanella, BC; Kufe, D; Mendoza, JT; Pantazis, P; Rubin, E | 1 |
| Gupta, E; Ibrahim, N; Li, XG; Mendoza, J; Pantazis, P; Patel, M; Rubin, EH; Saleem, A | 1 |
| Chatterjee, D; Han, Z; Pantazis, P; Wyche, J | 1 |
4 other study(ies) available for rubitecan and Leukemia
| Article | Year |
|---|---|
Sensitivity of camptothecin-resistant human leukemia cells and tumors to anticancer drugs with diverse mechanisms of action.
Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Cycle; Cell Division; DNA, Neoplasm; Drug Resistance; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Leukemia; Male; Mice; Mice, Nude; Topoisomerase II Inhibitors | 1995 |
Partial characterization of human leukemia U-937 cell sublines resistant to 9-nitrocamptothecin.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Adhesion; Cell Differentiation; Cell Division; DNA Topoisomerases, Type I; DNA, Neoplasm; Drug Resistance; Flow Cytometry; Humans; Leukemia; Male; Mice; Mice, Nude; Monocytes; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1994 |
Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning.
Topics: Antineoplastic Agents; Camptothecin; Cell Nucleus; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Etoposide; Humans; Leukemia; Phenotype; Point Mutation; RNA, Messenger; Tumor Cells, Cultured | 1997 |
Modulation of 9-nitrocamptothecin-induced apoptosis by hyperthermia in human leukemia HL-60 cells.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Flow Cytometry; HL-60 Cells; Humans; Hyperthermia, Induced; Leukemia | 1999 |